Piramal Pharma Limited
Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments(1) Contract development and manufacturing organisations (CDMO), (2) Complex hospital generics (critical care), and (3) consumer healthcare (OTC).Company entered Pharma space back in 1988 with acquisition of Nicholas Laboratories and grew through a series of Mergers & Acquisitionsand various organic…
What Piramal files
- Others47
- Investor Meet43
- Important30
- Updates25
- Board Meeting11
- PPTs8
Piramal Pharma (PPL) has acquired an additional 40.67% stake in Yapan Bio Private Limited for approximately ₹76 crores, increasing its total ownership to 74.00%. Yapan, now a PPL subsidiary, specializes as a Contract Development and Manufacturing Organization (CDMO) for vaccines and biologics. This strategic acquisition integrates Yapan's advanced large molecule...
Piramal Pharma has infused a significant ₹ 1,626.49 Cr into PPL Pharma Inc., its wholly-owned step-down subsidiary. This substantial capital infusion, through preference share subscription by Piramal Healthcare Inc., aims to fortify the subsidiary's financial standing. The move is a strategic internal deployment of capital to strengthen existing group assets,...
Piramal Pharma Limited’s wholly owned subsidiary, Piramal Healthcare Inc. (PHI), is set to invest USD 190.3 million (Rs. 1,626.49 crore) in PPL Pharma Inc. This transaction involves subscribing to 1,903 optionally convertible redeemable preference shares, financed through a combination of cash (USD 40.1 million) and the conversion of an outstanding...